Astragaloside IV prevents endothelial dysfunction by improving oxidative stress in streptozotocin‑induced diabetic mouse aortas
Open Access
- 20 August 2021
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 22 (5) , 1-10
Abstract
Oxidative stress serves a role in endothelial dysfunction exhibited by patients with diabetes mellitus. Astragaloside IV (AS‑IV) is a major active ingredient of Radix Astragali, which is considered to exhibit vasoprotective effects through unknown mechanisms. Thus, the current study was performed to investigate the protective effects of AS‑IV in streptozotocin (STZ)‑induced endothelial dysfunction and to explore whether antioxidant mechanisms were involved. The protective effects of AS‑IV on the endothelium‑dependent relaxation and contraction of aortic rings were determined by isometric tension recordings. NADPH subunits and endothelial nitric oxide synthase (eNOS) expression was identified via western blotting. Superoxide dismutase and malondialdehyde levels were assayed using ELISA. Furthermore, the generation of reactive oxygen species (ROS) and nitric oxide (NO) was detected via dihydroethidium and 4,5‑diaminofluorescein diacetate staining, respectively. The results revealed that STZ‑injected mice exhibited increased aortic endothelium‑dependent vasoconstriction and decreased vasorelaxation to acetylcholine. However, AS‑IV treatment reversed these effects. NG‑nitro‑L‑arginine was subsequently used to completely inhibit impaired relaxation. Accordingly, impaired NO generation was restored following AS‑IV treatment by increasing eNOS phosphorylation levels. Furthermore, ROS formation was also depressed following AS‑IV treatment compared with that in STZ‑injected mice. AS‑IV also decreased the expression of various NADPH subunits, including human neutrophil cytochrome b light chain, neutrophil cytosolic factor 1, NADPH oxidase (NOX)2, NOX4 and Rac‑1. The results of the current study may provide novel evidence that diabetes‑induced vascular injury arises from either the inhibition of eNOS or the activation of NOX‑derived ROS generation. In addition, the results warrant further investigation into the application of AS‑IV treatment, leading to the improvement of oxidative stress, in patients with diabetes exhibiting endothelial dysfunction.Keywords
This publication has 53 references indexed in Scilit:
- Role of ROCK upregulation in endothelial and smooth muscle vascular functions in diabetic rat aortaCardiovascular Diabetology, 2013
- Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targetsNature Reviews Drug Discovery, 2011
- Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed RatsMolecules, 2011
- Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunctionBasic Research in Cardiology, 2011
- Elevated systemic TGF-β impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE−/−miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Endothelial Dysfunction as a Target for Prevention of Cardiovascular DiseaseDiabetes Care, 2009
- Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cellsBritish Journal of Pharmacology, 2009
- Astragalosides Isolated from the Root of Astragalus Radix Inhibit the Formation of Advanced Glycation End ProductsJournal of Agricultural and Food Chemistry, 2009
- Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart StudyCirculation, 2009
- Nitric oxide detection by DAF (diaminofluorescein) fluorescence in human myometrial tissueGynecological Endocrinology, 2008